| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.008 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |